16.1 Assessment, Consent & Collaborative Care Planning
Key Takeaways
- Comprehensive infusion assessment integrates clinical condition, disease state, history, labs/diagnostics, and applied anatomy/physiology into a safe therapy and device plan.
- Verify patient identity with two identifiers and confirm the ordered therapy and device before invasive procedures or high-risk infusions.
- Informed consent for invasive access (PICC, port, etc.) requires capacity, disclosure of risks/benefits/alternatives, voluntary agreement, and documentation; emergency exceptions are narrow and still documented.
- Collaborative care planning includes the MD/APP, pharmacy, nutrition, and infection prevention when therapy complexity, nutrition, or infection risk demand team input.
- Patient and caregiver education uses teach-back for device care, infection warning signs, when to call, and home infusion safety—not one-way lecture alone.
Professional practice as the safety spine of infusion care
Quick Answer: Before you insert a device or start high-risk therapy, complete a comprehensive assessment, verify identity (two identifiers) + therapy + device, obtain and document informed consent when the procedure is invasive, build a collaborative plan with MD/APP, pharmacy, nutrition, and infection prevention as needed, and teach the patient/caregiver with teach-back. These steps map to CRNI Tasks focused on assessment, verification, consent, planning, and education.
Infusion nursing is high-risk specialty practice. Device insertion, vesicants, parenteral nutrition, biologics, and blood products all depend on judgment that starts long before the sterile field is opened. This section unifies the front-end professional tasks: know the patient, confirm the right person and plan, consent when required, coordinate the team, and educate for self-care and escalation.
Comprehensive assessment: from data to therapy plan
A comprehensive infusion assessment is not a single vital-sign check. It integrates:
| Assessment domain | What you evaluate | Why it drives the plan |
|---|---|---|
| Clinical condition | Stability, volume status, respiratory/cardiac status, mental status, acuity | Determines urgency, monitoring intensity, and whether outpatient/home therapy is safe |
| Disease state | Cancer, infection, malabsorption, heart failure, renal disease, immunodeficiency | Shapes therapy type, duration, vesicant risk, and infection vulnerability |
| History | Prior access attempts, DVT/CLABSI, allergies, antineoplastic exposure, mastectomy/AVF, home support | Avoids doomed sites, known allergens, and unsupported home plans |
| Labs & diagnostics | CBC, coagulation, renal/hepatic panels, cultures, imaging, prior line tip location | Informs bleeding risk, dose safety, infection workup, and device choice |
| A&P applied | Vein quality, chest/neck anatomy, skin integrity, body habitus, laterality constraints | Links anatomy to peripheral vs midline vs PICC vs port vs alternate routes |
Applying anatomy and physiology to the plan
Exam stems often reward the nurse who connects physiology to device and therapy:
- Poor peripheral veins + multi-week irritant therapy → escalate access strategy rather than serial failed short PIVs
- Superior vena cava anatomy and tip location rules for central devices
- Renal disease and fistula preservation → avoid preferred dialysis arm for casual peripheral sticks
- Immunocompromise → stricter infection prevention and lower threshold to investigate fever with a central line
- Heart failure + large-volume fluids → rate/volume caution and overload monitoring
Document findings that change the plan (for example, “left arm lymphedema—use right upper extremity only”) so the entire team shares the constraint.
Therapy-device congruence
Assessment ends with a coherent plan: prescribed therapy characteristics (osmolarity, pH, vesicant/irritant status, duration, ambulatory vs continuous) must match a device that can safely deliver it. If they do not match, collaborate and escalate—do not force a short PIV to carry multi-week PN or continuous vesicants.
Verify patient identity, therapy, and device
Two-identifier verification is a National Patient Safety Goal concept and a non-negotiable infusion habit. Typical identifiers are name + date of birth (or another facility-approved pair)—never room number alone. Verification is required:
- Before invasive procedures (PICC, midline, port access for high-risk therapy, etc.)
- Before blood product administration
- Before high-alert infusions and independent double-checks when policy requires
- At handoff when the plan or device changes
Also verify the therapy (drug/fluid, dose, route, rate, concentration) and the device (type, site, patency, lumen, tip confirmation status when relevant). Wrong-patient therapy and wrong-route/wrong-device events are preventable system failures. On the exam, “skip verification because you know the patient” is always wrong.
Informed consent: elements, capacity, emergencies
Core elements
Informed consent for invasive infusion procedures (for example PICC insertion, implanted port placement/access for certain contexts, other invasive vascular access per policy) generally requires:
- Capacity — the patient can understand information, appreciate consequences, reason about options, and communicate a choice (or a legally authorized representative acts)
- Disclosure — purpose of the procedure, benefits, material risks (infection, thrombosis, bleeding, pneumothorax for certain central approaches, malposition, need for replacement), and alternatives (including no procedure when clinically relevant)
- Voluntariness — free of coercion
- Documentation — consent obtained, who consented, what was discussed at a level required by policy, and any questions answered
The nurse’s role may include witnessing, verifying consent is present before the procedure, providing education consistent with the plan, and advocating if the patient does not understand or appears pressured. Facility policy and state law define who obtains procedural consent (often the inserting provider) and what the RN documents.
Capacity red flags
Acute delirium, heavy sedation, untreated hypoxia, or severe pain-impairment may temporarily remove capacity. Do not treat a signature alone as consent if the patient clearly cannot comprehend. Escalate to the provider and use surrogate decision-makers per law/policy when the patient lacks capacity.
Emergency exceptions
Emergency exceptions apply when immediate life-saving intervention is required and delay to obtain consent would cause serious harm, and no authorized decision-maker is available in time. Even then:
- Provide only care necessary to address the emergency
- Document the emergency rationale, attempts to reach surrogates if any, and what was done
- Obtain formal consent for ongoing non-emergent care as soon as feasible
Routine elective PICC placement is not an emergency exception scenario. Exam traps that skip consent “to save time” on a stable patient are incorrect.
Collaborative care planning
Safe infusion therapy is a team sport:
| Partner | Typical contribution |
|---|---|
| MD / APP | Diagnosis, orders, goals of therapy, procedural authorization, escalation decisions |
| Pharmacy | Compatibility, concentration, stability, dosing, hazardous-drug handling, smart-pump library alignment |
| Nutrition | PN indication, formulation goals, refeeding risk, enteral vs parenteral decisions |
| Infection prevention | CLABSI surveillance definitions, bundle coaching, outbreak response, isolation implications |
| Others as needed | Case management/home infusion for discharge readiness; radiology for tip confirmation; wound/ostomy for complex skin |
Collaboration is not optional decoration—it is how you prevent incompatible mixtures, under-resourced home plans, and “silent” infection risks. When assessment reveals polypharmacy, multi-lumen needs, or malnutrition, initiate the right consult early.
Patient and caregiver education with teach-back
Education is a professional task equal to insertion skill. Prioritize:
- Device care basics: hand hygiene, dressing integrity, no pulling/tugging, activity limits per device type
- Infection signs: fever, chills, site redness/swelling/drainage, new pain, malaise—when to call immediately vs routine clinic contact
- Occlusion/damage cues: inability to flush, leaking, cracked hub, wet dressing
- Home infusion teaching: pump operation at a user level, storage of solutions, disposal of sharps, who to call 24/7, backup plan for alarms
- Therapy-specific warnings: extravasation pain for vesicants, reaction signs for first-dose biologics, overload signs for large-volume fluids
Use teach-back: ask the patient/caregiver to explain in their own words or demonstrate a step (for example, “Show me how you would clean the hub”). Failure of teach-back means re-teach, simplify language, use an interpreter when language is a barrier, and involve another caregiver—not “they nodded so they understand.” Document what was taught, who was present, materials given, and teach-back outcome.
Putting the sequence together for exam thinking
- Assess comprehensively and apply A&P
- Verify two identifiers + therapy + device
- Consent (capacity, elements, document; emergency only when true emergency)
- Plan collaboratively across disciplines
- Educate with teach-back and clear call parameters
Master this sequence and you protect autonomy, safety, and continuity from hospital insertion through home infusion follow-up.
Before PICC insertion for planned multi-week outpatient antibiotics, which action best reflects professional verification practice?
Which set best captures essential elements of informed consent for an invasive vascular access procedure?
A stable patient is scheduled for elective PICC placement. Consent has not been obtained. What is the most appropriate action?
Which education method best confirms that a home infusion caregiver understands hub disinfection and when to call for fever?